Last Updated on June 22, 2023

Japanese Journal of Cancer and Chemotherapy- Impact Score, Ranking, SJR, h-index, Citescore, Rating, Publisher, ISSN, and Other Important Details


Published By: Japanese Journal of Cancer and Chemotherapy Publishers Inc.

Abbreviation: Jpn. J. Cancer Chemother.




Impact Score

The impact Score or journal impact score (JIS) is equivalent to Impact Factor. The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate's Web of Science. On the other hand, Impact Score is based on Scopus data.

0.11

SJR

 0.116

h-Index

 25

Rank

 24604

Important Details

Title Japanese Journal of Cancer and Chemotherapy
Standard Abbreviation Jpn. J. Cancer Chemother.
Type of Publication Journal
Discipline Cancer Research (Q4); Medicine (miscellaneous) (Q4); Oncology (Q4)
Impact Score 0.11
SCImago Journal Rank (SJR) 0.116
h-index 25
Overall Rank 24604
Publisher Name Japanese Journal of Cancer and Chemotherapy Publishers Inc.
Publication Country Japan
International Standard Serial Number (ISSN) 03850684
Coverage and History 1979-2022
Best Quartile Q4
Total Citations Received
(Last 3 Year)
220

About Japanese Journal of Cancer and Chemotherapy


Japanese Journal of Cancer and Chemotherapy is a journal published by Japanese Journal of Cancer and Chemotherapy Publishers Inc.. This journal covers the area[s] related to Cancer Research, Medicine (miscellaneous), Oncology, etc. The coverage history of this journal is as follows: 1979-2022. The rank of this journal is 24604. This journal's impact score, h-index, and SJR are 0.11, 25, and 0.116, respectively. The ISSN of this journal is/are as follows: 03850684.

The best quartile of Japanese Journal of Cancer and Chemotherapy is Q4. This journal has received a total of 220 citations during the last three years (Preceding 2022).


Japanese Journal of Cancer and Chemotherapy Impact Score 2022-2023


The latest impact score (IS) of the Japanese Journal of Cancer and Chemotherapy is 0.11. It is computed in the year 2023 as per its definition and based on Scopus data. 0.11

It is increased by a factor of around 0.01, and the percentage change is 10% compared to the preceding year 2021, indicating a rising trend.

The impact score (IS), also denoted as the Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Prediction of Japanese Journal of Cancer and Chemotherapy Impact Score 2023


Impact Score 2022 of Japanese Journal of Cancer and Chemotherapy is 0.11. If a similar upward trend continues, IS may increase in 2023 as well.


Impact Score Graph


Check below the Impact Score trends of Japanese Journal of Cancer and Chemotherapy. This is based on Scopus data.


Year Impact Score (IS)
2023/2024 Coming Soon
2022 0.11
2021 0.10
2020 0.09
2019 0.07
2018 0.07
2017 0.09
2016 0.09
2015 0.13
2014 0.12

Japanese Journal of Cancer and Chemotherapy h-index


  Table Setting

The h-index of Japanese Journal of Cancer and Chemotherapy is 25. By definition of the h-index, this journal has at least 25 published articles with more than 25 citations.

What is h-index?

The h-index (also known as the Hirsch index or Hirsh index) is a scientometric parameter used to evaluate the scientific impact of the publications and journals. It is defined as the maximum value of h such that the given Journal has published at least h papers and each has at least h citations.




Japanese Journal of Cancer and Chemotherapy ISSN


The International Standard Serial Number (ISSN) of Japanese Journal of Cancer and Chemotherapy is/are as follows: 03850684.

The ISSN is a unique 8-digit identifier for a specific publication like Magazine or Journal. The ISSN is used in the postal system and in the publishing world to identify the articles that are published in journals, magazines, newsletters, etc. This is the number assigned to your article by the publisher, and it is the one you will use to reference your article within the library catalogues.

ISSN code (also called as "ISSN structure" or "ISSN syntax") can be expressed as follows: NNNN-NNNC
Here, N is in the set {0,1,2,3...,9}, a digit character, and C is in {0,1,2,3,...,9,X}

Table Setting

Japanese Journal of Cancer and Chemotherapy Ranking and SCImago Journal Rank (SJR)


The Japanese Journal of Cancer and Chemotherapy is ranked 24604 among 27955 Journals, Conferences, and Book Series. As per SJR, this journal is ranked 0.116.

SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


Japanese Journal of Cancer and Chemotherapy Publisher


Table Setting

The publisher of Japanese Journal of Cancer and Chemotherapy is Japanese Journal of Cancer and Chemotherapy Publishers Inc.. The publishing house of this journal is located in the Japan. Its coverage history is as follows: 1979-2022.


Call For Papers (CFPs)


Please check the official website of this journal to find out the complete details and Call For Papers (CFPs).


Abbreviation


The International Organization for Standardization 4 (ISO 4) abbreviation of Japanese Journal of Cancer and Chemotherapy is Jpn. J. Cancer Chemother.. ISO 4 is an international standard which defines a uniform and consistent system for the abbreviation of serial publication titles, which are published regularly. The primary use of ISO 4 is to abbreviate or shorten the names of scientific journals using the technique of List of Title Word Abbreviations (LTWA).

As ISO 4 is an international standard, the abbreviation ('Jpn. J. Cancer Chemother.') can be used for citing, indexing, abstraction, and referencing purposes.


How to publish in Japanese Journal of Cancer and Chemotherapy


If your area of research or discipline is related to Cancer Research, Medicine (miscellaneous), Oncology, etc., please check the journal's official website to understand the complete publication process.


Acceptance Rate


There are several factors that influence the acceptance rate of any academic journal. Here are some critical parameters that are considered while calculating the acceptance rate:

  • Interest/demand of researchers/scientists for publishing in a specific journal/conference.
  • The complexity of the peer review process and timeline.
  • Time taken from draft submission to final publication.
  • Number of submissions received and acceptance slots
  • And Many More.

The simplest way to find out the acceptance rate or rejection rate of a Journal/Conference is to check with the journal's/conference's editorial team through emails or through the official website.



Frequently Asked Questions (FAQ)


What is the impact score of Japanese Journal of Cancer and Chemotherapy?

The latest impact score of Japanese Journal of Cancer and Chemotherapy is 0.11. It is computed in the year 2023.


What is the h-index of Japanese Journal of Cancer and Chemotherapy?

The latest h-index of Japanese Journal of Cancer and Chemotherapy is 25. It is evaluated in the year 2023.


What is the SCImago Journal Rank (SJR) of Japanese Journal of Cancer and Chemotherapy?

The latest SCImago Journal Rank (SJR) of Japanese Journal of Cancer and Chemotherapy is 0.116. It is calculated in the year 2023.


What is the ranking of Japanese Journal of Cancer and Chemotherapy?

The latest ranking of Japanese Journal of Cancer and Chemotherapy is 24604. This ranking is among 27955 Journals, Conferences, and Book Series. It is computed in the year 2023.


Who is the publisher of Japanese Journal of Cancer and Chemotherapy?

Japanese Journal of Cancer and Chemotherapy is published by Japanese Journal of Cancer and Chemotherapy Publishers Inc.. The publication country of this journal is Japan.


What is the abbreviation of Japanese Journal of Cancer and Chemotherapy?

This standard abbreviation of Japanese Journal of Cancer and Chemotherapy is Jpn. J. Cancer Chemother..


Is "Japanese Journal of Cancer and Chemotherapy" a Journal, Conference or Book Series?

Japanese Journal of Cancer and Chemotherapy is a journal published by Japanese Journal of Cancer and Chemotherapy Publishers Inc..


What is the scope of Japanese Journal of Cancer and Chemotherapy?

The scope of Japanese Journal of Cancer and Chemotherapy is as follows:

  • Cancer Research
  • Medicine (miscellaneous)
  • Oncology

For detailed scope of Japanese Journal of Cancer and Chemotherapy, check the official website of this journal.


What is the ISSN of Japanese Journal of Cancer and Chemotherapy?

The International Standard Serial Number (ISSN) of Japanese Journal of Cancer and Chemotherapy is/are as follows: 03850684.


What is the best quartile for Japanese Journal of Cancer and Chemotherapy?

The best quartile for Japanese Journal of Cancer and Chemotherapy is Q4.


What is the coverage history of Japanese Journal of Cancer and Chemotherapy?

The coverage history of Japanese Journal of Cancer and Chemotherapy is as follows 1979-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/
  • Issn.org, https://www.issn.org/
  • Scopus, https://www.scopus.com/

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.


Impact Score, SJR, h-Index, and Other Important metrics of These Journals, Conferences, and Book Series


Journal/Conference/Book Title Type Publisher Ranking SJR h-index Impact Score
Criminal Justice Review Journal SAGE Publications Inc. 8738 41 1.30
Journal of International Financial Management and Accounting Journal Wiley-Blackwell Publishing Ltd 6179 42 6.09
Archives of Phytopathology and Plant Protection Journal Taylor and Francis Ltd. 14852 29 1.14
Journal, Indian Academy of Clinical Medicine Journal Indian Academy of Clinical Medicine 24608 16 0.06
Sex Education Journal Routledge 5168 41 2.82
Genes and Nutrition Journal BioMed Central Ltd. 6154 61 3.28
Acta Periodica Technologica Journal University of Novi Sad, Faculty of Technology 19470 18 0.62
Journal of Sociology Journal SAGE Publications Ltd 6009 58 3.21
Proceedings of the ACM SIGKDD International Conference on Knowledge Discovery and Data Mining Conference And Proceedings 4334 192 0.00
Clinical Interventions in Aging Journal Dove Medical Press Ltd. 4777 96 3.57

Check complete list




Japanese Journal of Cancer and Chemotherapy Impact Score (IS) Trend

Table: Impact Score

Year Impact Score (IS)
2023/2024 Updated Soon
2022 0.11
2021 0.10
2020 0.09
2019 0.07
2018 0.07
2017 0.09
2016 0.09
2015 0.13
2014 0.12



Top Journals/Conferences in Cancer Research

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Cell Host and Microbe
Cell Press | United States

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Nature Cancer
| United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

JAMA Oncology
American Medical Association | United States

Signal Transduction and Targeted Therapy
Springer Nature | United Kingdom

Journal of Hematology and Oncology
BioMed Central Ltd. | United Kingdom

Journal of the National Cancer Institute
Oxford University Press | United Kingdom

Neuro-Oncology
Oxford University Press | United Kingdom

Clinical Cancer Research
American Association for Cancer Research Inc. | United States

Annual Review of Cancer Biology
Annual Reviews Inc. | United States

Drug Resistance Updates
Churchill Livingstone | United States

Trends in Cancer
Cell Press | United States

See All

Top Journals/Conferences in Medicine (miscellaneous)

New England Journal of Medicine
Massachussetts Medical Society | United States

Nature Medicine
Nature Publishing Group | United Kingdom

MMWR Recommendations and Reports
Centers for Disease Control and Prevention (CDC) | United States

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Nature Reviews Immunology
Nature Publishing Group | United Kingdom

Morbidity and Mortality Weekly Report
Department of Health and Human Services | United States

Lancet, The
Elsevier Ltd. | United Kingdom

Physiological Reviews
American Physiological Society | United States

MMWR supplements
Epidemiology Program Office | United States

Annals of Oncology
Elsevier Ltd. | United Kingdom

Nature Reviews Disease Primers
Nature Publishing Group | United Kingdom

Current Protocols in Bioinformatics
John Wiley & Sons Inc. | United States

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Annual Review of Public Health
Annual Reviews Inc. | United States

Nature Reviews Methods Primers
Springer Nature | United States

See All

Top Journals/Conferences in Oncology

Ca-A Cancer Journal for Clinicians
Wiley-Blackwell | United States

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Nature Reviews Clinical Oncology
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Lancet Oncology, The
Elsevier Ltd. | United Kingdom

Annals of Oncology
Elsevier Ltd. | United Kingdom

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Nature Cancer
| United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

JAMA Oncology
American Medical Association | United States

Cancer Discovery
American Association for Cancer Research Inc. | United States

Lancet Regional Health - Europe, The
Elsevier Ltd. | United Kingdom

Journal of Hematology and Oncology
BioMed Central Ltd. | United Kingdom

Journal of Thoracic Oncology
International Association for the Study of Lung Cancer | United States

Journal of the National Cancer Institute
Oxford University Press | United Kingdom

See All